Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03607500 · ClinicalTrials.gov registry record · NA
Effect of Moderate Caloric Restriction on Glomerular Growth After Kidney Transplantation
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03607500: Clinical Trial NA study, sponsored by University of Michigan.
NCT03607500 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03607500, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
One possible reason that weight gain after transplant may interfere with new kidney function is due to the enlargement of a kidney structure called the glomerulus. The researchers believe that modest caloric intake reduction (CIR) early after kidney transplantation can reduce the enlargement (hypertrophy) of the glomerulus associated with kidney transplantation and may improve long term allograft survival, by reducing glomerular hypertrophy mediated progressive glomerulosclerosis.
Interventions
- BEHAVIORAL caloric intake reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-08-22 |
| Est. Completion | 2021-08-16 |
| Phase | NA |
Why NCT03607500 stopped before completion
NCT03607500 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which caloric intake reduction is the first listed.
NCT03607500 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03607500 about?
NCT03607500 is a clinical study titled "Effect of Moderate Caloric Restriction on Glomerular Growth After Kidney Transplantation". One possible reason that weight gain after transplant may interfere with new kidney function is due to the enlargement of a kidney structure called the glomerulus. The researchers believe that modest caloric intake reduction (CIR) early after kidney transplantation can reduce the enlargement (hyper...
What is the current status of trial NCT03607500?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-08-22. Estimated completion is 2021-08-16.
What interventions are being tested in trial NCT03607500?
The interventions under investigation include: caloric intake reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT03607500?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03607500's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI